A Study to Evaluate Role of Inhaled Amikacin to Prevent Ventilator Associated Pneumonia in Patients With Cirrhosis

NCT06808074 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

162

Enrollment

OTHER

Sponsor class

Conditions

Hepatic Encephalopathy
Cirrhosis
Ventilator Associated Pneumonia (VAP)

Interventions

DRUG: Inhaled amikacin
DRUG: Placebo

Sponsor

Asian Institute of Gastroenterology, India